Syros Pharmaceuticals, Inc.
Pyrrolotriazine compounds and methods of inhibiting TAM kinases
Last updated:
Abstract:
Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat cancer.
Status:
Grant
Type:
Utility
Filling date:
9 Oct 2018
Issue date:
22 Jun 2021